8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 4, 2026 · 25d ago · Accession 0001193125-26-257365
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Trevi Therapeutics, Inc.
- Ticker
- TRVI
- CIK
- 1563880
- Form type
- 8-K
- Filing date
- Jun 4, 2026
- Report date
- Jun 3, 2026
- Document
- trvi-20260603.htm
- Size
- 222 KB